ELEFTHA 150mg Injection is a biologic therapy designed to treat moderate to severe autoimmune conditions, such as rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The active ingredient, Etanercept, is a tumor necrosis factor (TNF)-alpha inhibitor that works by blocking the action of TNF-alpha, a protein involved in inflammation and immune system dysfunction. By inhibiting TNF-alpha, ELEFTHA reduces inflammation, alleviates pain, and prevents joint damage associated with these conditions.

Key Features:

• Active Ingredient: Etanercept, a TNF-alpha inhibitor.
• Indications: Treats moderate to severe rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and other autoimmune conditions.
• Mechanism of Action: Blocks TNF-alpha to reduce inflammation and prevent joint damage.
• Administration: Administered via subcutaneous injection, typically once a week or as prescribed by a healthcare provider.
• Effectiveness: Helps reduce symptoms, improve joint function, and prevent disease progression.

Benefits:

• Alleviates pain and swelling associated with autoimmune diseases.
• Improves joint function and mobility.
• Reduces the risk of joint damage and long-term disability.
• Enhances overall quality of life for patients with chronic inflammatory conditions.

Precautions: Before starting treatment with ELEFTHA, patients should inform their healthcare provider about any infections, previous history of tuberculosis, or other health conditions. Regular monitoring for side effects such as infections or liver problems is advised during treatment.

Side Effects: Common side effects may include injection site reactions, headache, and upper respiratory tract infections. Serious incidental effects are interesting yet can incorporate extreme hypersensitive responses or contaminations.

FAQs:

1. What is ELEFTHA 150mg Injection used for?

ELEFTHA 150mg Injection is used to treat moderate to severe autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and other inflammatory conditions. It helps reduce inflammation, alleviate pain, and prevent joint damage by inhibiting TNF-alpha, a protein responsible for inflammation.

2. How does ELEFTHA 150mg Injection work?

ELEFTHA contains Etanercept, a TNF-alpha inhibitor that blocks the action of tumor necrosis factor (TNF), a protein involved in the inflammatory process. By blocking TNF, it reduces inflammation, relieves pain, and helps prevent further joint damage associated with autoimmune diseases.

3. How is ELEFTHA 150mg Injection administered?

ELEFTHA 150mg Injection is administered subcutaneously (under the skin) by a healthcare provider. It is typically given once a week or as prescribed by your doctor, depending on the condition being treated.

4. Can ELEFTHA 150mg Injection cure autoimmune diseases?

ELEFTHA 150mg Injection does not cure autoimmune diseases, but it helps manage symptoms, reduce inflammation, and prevent joint damage. It can significantly improve the quality of life for people with chronic inflammatory conditions by controlling disease activity.

5. Can I take ELEFTHA 150mg Injection while pregnant or breastfeeding?

The safety of ELEFTHA during pregnancy or breastfeeding has not been fully established. It is essential to consult your doctor before using this medication if you are pregnant, planning to conceive, or breastfeeding.

6. Can I drink alcohol while receiving ELEFTHA 150mg Injection?

It is advisable to limit alcohol consumption while receiving treatment with ELEFTHA. Alcohol may increase the risk of side effects, such as liver problems, and interfere with your overall health.

7. How often do I need to receive ELEFTHA 150mg Injection?

The frequency of ELEFTHA 150mg Injection depends on the condition being treated. Typically, it is administered once a week. Your doctor will provide a treatment schedule based on your response to therapy and the condition you are managing.